These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 22213608)
1. Early Impact of the US Tdap vaccination program on pertussis trends. Skoff TH; Cohn AC; Clark TA; Messonnier NE; Martin SW Arch Pediatr Adolesc Med; 2012 Apr; 166(4):344-9. PubMed ID: 22213608 [TBL] [Abstract][Full Text] [Related]
2. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
3. Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis. Skoff TH; Martin SW JAMA Pediatr; 2016 May; 170(5):453-8. PubMed ID: 27018748 [TBL] [Abstract][Full Text] [Related]
4. Pertussis in adolescents and adults: should we vaccinate? Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232 [TBL] [Abstract][Full Text] [Related]
5. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763 [TBL] [Abstract][Full Text] [Related]
6. US Infant Pertussis Incidence Trends Before and After Implementation of the Maternal Tetanus, Diphtheria, and Pertussis Vaccine. Skoff TH; Deng L; Bozio CH; Hariri S JAMA Pediatr; 2023 Apr; 177(4):395-400. PubMed ID: 36745442 [TBL] [Abstract][Full Text] [Related]
7. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(40):1302-6. PubMed ID: 20948508 [TBL] [Abstract][Full Text] [Related]
8. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953 [TBL] [Abstract][Full Text] [Related]
9. Waning Tdap Effectiveness in Adolescents. Klein NP; Bartlett J; Fireman B; Baxter R Pediatrics; 2016 Mar; 137(3):e20153326. PubMed ID: 26908667 [TBL] [Abstract][Full Text] [Related]
10. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases. Talbird SE; Graham J; Mauskopf J; Masseria C; Krishnarajah G J Manag Care Spec Pharm; 2015 Jan; 21(1):88-99, 99a-c. PubMed ID: 25562776 [TBL] [Abstract][Full Text] [Related]
11. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328 [TBL] [Abstract][Full Text] [Related]
12. Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: King County, Washington, 2002 through 2007. Hanson MP; Kwan-Gett TS; Baer A; Rietberg K; Ohrt M; Duchin JS Arch Pediatr Adolesc Med; 2011 Jul; 165(7):647-52. PubMed ID: 21727277 [TBL] [Abstract][Full Text] [Related]
13. Pertussis--United States, 2001-2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2005 Dec; 54(50):1283-6. PubMed ID: 16371944 [TBL] [Abstract][Full Text] [Related]
14. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Jul; 57(29):796-9. PubMed ID: 18650787 [TBL] [Abstract][Full Text] [Related]
15. Infant hospitalizations for pertussis before and after Tdap recommendations for adolescents. Auger KA; Patrick SW; Davis MM Pediatrics; 2013 Nov; 132(5):e1149-55. PubMed ID: 24144713 [TBL] [Abstract][Full Text] [Related]
16. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379 [TBL] [Abstract][Full Text] [Related]
17. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Terranella A; Asay GR; Messonnier ML; Clark TA; Liang JL Pediatrics; 2013 Jun; 131(6):e1748-56. PubMed ID: 23713104 [TBL] [Abstract][Full Text] [Related]
18. Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use. Hitchcock WP Clin Pediatr (Phila); 2006 Nov; 45(9):785-94. PubMed ID: 17041165 [TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737 [TBL] [Abstract][Full Text] [Related]
20. Pertussis epidemic--Washington, 2012. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Jul; 61(28):517-22. PubMed ID: 22810264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]